| 24.18 0.3 (1.26%) | 05-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 29.39 | 1-year : | 34.33 |
| Resists | First : | 25.17 | Second : | 29.39 |
| Pivot price | 23.71 |
|||
| Supports | First : | 22.98 |
Second : | 21.62 |
| MAs | MA(5) : | 23.78  |
MA(20) : | 23.49 |
| MA(100) : | 22.41 |
MA(250) : | 21.67 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 48.1 |
D(3) : | 45.1 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 25.17 | Low : | 17.67 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KVUE ] has closed below upper band by 20.2%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 24.27 - 24.39 | 24.39 - 24.49 |
| Low: | 23.61 - 23.75 | 23.75 - 23.87 |
| Close: | 23.96 - 24.18 | 24.18 - 24.38 |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Sat, 17 May 2025
Kenvue (NYSE:KVUE) Given New $23.00 Price Target at Barclays - MarketBeat
Sat, 17 May 2025
Gotham Asset Management LLC Lowers Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Fri, 16 May 2025
Cary Street Partners Financial LLC Makes New $270,000 Investment in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Fri, 16 May 2025
Thousands of Kenvue Employees Come Together Across 21 Market - 3BL Media
Thu, 15 May 2025
AQR Capital Management LLC Sells 131,494 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Thu, 15 May 2025
Lee Ainslie's Strategic Moves: A Deep Dive into Kenvue Inc's 3.59% Portfolio Impact - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 1,920 (M) |
| Shares Float | 1,910 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 102.4 (%) |
| Shares Short | 40,730 (K) |
| Shares Short P.Month | 37,960 (K) |
| EPS | 0.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.05 |
| Profit Margin | 6.9 % |
| Operating Margin | 17.8 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -4 % |
| Gross Profit (p.s.) | 4.63 |
| Sales Per Share | 7.96 |
| EBITDA (p.s.) | 1.81 |
| Qtrly Earnings Growth | 12.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 43.17 |
| PEG Ratio | 0 |
| Price to Book value | 4.78 |
| Price to Sales | 3.03 |
| Price to Cash Flow | 0 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|